필요한 CMO/CDMO 검색 및 찾기
귀하의 약물 개발 및 제조 프로젝트를 위한 고도로 숙련된 파트너를 찾아보세요.
치료 전문 분야(ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (V09-10) Radiopharmaceuticals, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
OEB(직업 노출 밴딩): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
시장: NMPA (China), FDA (USA)
지역: APAC
규정 준수: FDA (cGMP), ISO, NMPA (China GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
카테고리 / 제품: 화학합성
서비스: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
치료 전문 분야(ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), MHRA (UK), MFDS (South Korea), TGA (Australia)
지역: 유럽
규정 준수: FDA (cGMP), PMDA/MHLW (Japan GMP), TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
카테고리 / 제품: 화학합성
서비스: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
OEB(직업 노출 밴딩): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
치료 전문 분야(ATC): (V04) Diagnostic agents, (C) Cardiovascular system, (D) Dermatologicals, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (P) Antiparasitic products, insecticides and repellents, (R) Respiratory system, (S) Sensory organs, (V01) Allergens, (V06) Nutrients, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, High potential for abuse & no medical use, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), MHRA (UK), MFDS (South Korea), TGA (Australia)
규정 준수: FDA (cGMP), ISO, ECOVADIS
배치 크기: Large, Small, Medium
사용: Human, Veterinary
카테고리 / 제품: 화학합성
서비스: Development services, Manufacturing services
OEB(직업 노출 밴딩): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
지역: 북아메리카
시장: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
규정 준수: DIGEMID, FDA (cGMP), ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), MSPAS, COFEPRIS, INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
BSL(생물학적 안전 수준): 1, 2
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: 생물학, FDF/의약품
시장: EMA (EU), MHRA (UK), TGA (Australia)
지역: 유럽
사용: Human, Veterinary
BSL(생물학적 안전 수준): 1
서비스: Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
OEB(직업 노출 밴딩): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
배치 크기: Small, Medium
규정 준수: EMA (EU GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP)
카테고리 / 제품: FDF/의약품
BSL(생물학적 안전 수준): 3, 1, 2
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
규정 준수: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
규제 물질: Lowest potential for abuse
OEB(직업 노출 밴딩): 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
지역: 북아메리카
카테고리 / 제품: FDF/의약품
53Biologics Production Plant
53Biologics
53Biologics는 DNA에서 단백질에 이르기까지 생물학적 제제 생산을 해독하는 데 특화된 스페인 CDMO입니다.
시장: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services
지역: 유럽
규정 준수: FDA (cGMP), ISO, EMA (EU GMP), World Health Organization (GMP / HACCP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
BSL(생물학적 안전 수준): 1, 2
카테고리 / 제품: 생물학
BDI biotech Production Plant
BDI biotech
우리는 균주 및 바이오프로세스 개발, 규모 확대 및 배치 생산을 전문으로 하는 R&D 부서로 일하고 있습니다.
시장: EMA (EU), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), TGA (Australia)
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Regulatory services
지역: 유럽
규정 준수: ISO
BSL(생물학적 안전 수준): 1
배치 크기: Small, Medium
카테고리 / 제품: 생물학
시장: EMA (EU), FDA (USA), ANVISA (Brazil), ANMAT (Argentina), MFDS (South Korea), TGA (Australia)
서비스: Logistics, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
지역: 유럽
규정 준수: FDA (cGMP), ISO, ANVISA (Brazil B-GMP), ECOVADIS, TGA (Australia GMP), INVIMA, ISP (Chile BPM), ANMAT (Argentina nueva GMP), EMA (EU GMP), Health Canada (Canada GMP), World Health Organization (GMP / HACCP), MHRA (UK GMP), MFDS/KFDA (Republic of Korea GMP)
배치 크기: Large, Small, Medium
사용: Human, Veterinary
치료 전문 분야(ATC): (C) Cardiovascular system, (J) Antiinfectives for systemic use, (M) Musculoskeletal system, (N) Nervous system, (A) Digestive tract and metabolism
규제 물질: Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
카테고리 / 제품: FDF/의약품
OEB(직업 노출 밴딩): 5 / HPAPI (PDE < 10 µg/day), 4 / HPAPI (PDE = 10 - 100 µg/day), 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
시장: EMA (EU), PMDA (Japan), NMPA (China), FDA (USA), Health Canada (Canada), ANVISA (Brazil), ISP (Chile), MSPAS (Guatemala), COFEPRIS (Mexico), DIGEMID (Peru), Russian Health Authorities, MHRA (UK), ANMAT (Argentina), INVIMA (Colombia), SFDA (Saudi Arabia), MFDS (South Korea), Turkish Health Authorities, EDE (UAE), CDSCO (India), TGA (Australia), Rest of World
서비스: Logistics, Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Regulatory services, Packaging
지역: 유럽
규정 준수: ISO, PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), TITCK (Turkish Health Authorities), NMPA (China GMP), EMA (EU GMP), MFDS/KFDA (Republic of Korea GMP)
배치 크기: Large, Small, Medium
사용: Human
BSL(생물학적 안전 수준): 1, 2
치료 전문 분야(ATC): (H) Systemic hormonal preparations excl. sex hormones and insulins, (L) Antineoplastic and immunomodulating agents, (N) Nervous system
카테고리 / 제품: FDF/의약품
ALPHAVET Zrt.- Bábolna Manufacturing Plant
Alphavet Zrt.
이 공장은 EU GMP 인증을 받았으며 18개 EU 회원국과 EU 이외의 7개 유럽 국가를 위한 동물용 의약품을 생산합니다.
시장: EMA (EU)
지역: 유럽
규정 준수: ISO, EMA (EU GMP)
배치 크기: Large, Medium
카테고리 / 제품: 영양식품, FDF/의약품
사용: Veterinary
서비스: Manufacturing services, Analytical / QC services, Regulatory services, Packaging
Avara Pharmaceutical Services | Arecibo Site
AVARA
규제 물질(DEA II V)에 대한 강력한 전문 지식을 갖춘 상업용 규모의 경구용 고형제(OSD) 제조 시설.
규제 물질: High potential for abuse & medical use, Lowest potential for abuse, Low potential for abuse, Lower potential for abuse
규정 준수: ICH, FDA (cGMP), PMDA/MHLW (Japan GMP), ANVISA (Brazil B-GMP), Roszdravnadzor (Russia GMP), EMA (EU GMP), Health Canada (Canada GMP), MFDS/KFDA (Republic of Korea GMP)
시장: EMA (EU), PMDA (Japan), FDA (USA), Health Canada (Canada), ANVISA (Brazil), Russian Health Authorities, MFDS (South Korea), TGA (Australia)
배치 크기: Large, Medium
사용: Human
카테고리 / 제품: 화학합성, 서비스, FDF/의약품, 입자공학
서비스: Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging
치료 전문 분야(ATC): (C) Cardiovascular system, (H) Systemic hormonal preparations excl. sex hormones and insulins, (J) Antiinfectives for systemic use, (L) Antineoplastic and immunomodulating agents, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system, (S) Sensory organs, (B) Blood and blood forming organs, (A) Digestive tract and metabolism, (G) Genito urinary system and sex hormones
지역: 북아메리카
OEB(직업 노출 밴딩): 2 (PDE = 1,000 - 10,000 µg/day), 3 (PDE = 100 - 1,000 µg/day), 1 / low-hazard (PDE > 10,000 µg/day)